Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Joanne Y.T. Leung, Alasdair M. Barr, Ric M. Procyshyn, et al.
Pharmacology & Therapeutics (2012) Vol. 135, Iss. 2, pp. 113-122
Closed Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthøj, Anne Emilie Stürup, John J. McGrath, et al.
The Lancet Psychiatry (2017) Vol. 4, Iss. 4, pp. 295-301
Closed Access | Times Cited: 1055
Management of common adverse effects of antipsychotic medications
T. Scott Stroup, Noel‐Marie Gray
World Psychiatry (2018) Vol. 17, Iss. 3, pp. 341-356
Open Access | Times Cited: 442
Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Brenda W.J.H. Penninx, Sjors M. M. Lange
Dialogues in Clinical Neuroscience (2018) Vol. 20, Iss. 1, pp. 63-73
Open Access | Times Cited: 432
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
William J. Panenka, Ric M. Procyshyn, Tania Lecomte, et al.
Drug and Alcohol Dependence (2012) Vol. 129, Iss. 3, pp. 167-179
Closed Access | Times Cited: 392
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope
Michele Brignole, Andrés Moyá, Frederik J. de Lange, et al.
European Heart Journal (2018) Vol. 39, Iss. 21, pp. e43-e80
Open Access | Times Cited: 189
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 62
Iloperidone, asenapine and lurasidone: a primer on their current status
Frank I. Tarazi, Stephen M. Stahl
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 13, pp. 1911-1922
Closed Access | Times Cited: 195
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Lurdes Tse, Alasdair M. Barr, Vanessa Scarapicchia, et al.
Current Neuropharmacology (2015) Vol. 13, Iss. 3, pp. 395-406
Open Access | Times Cited: 155
Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
Gary S. Sachs, William M. Greenberg, Anju Starace, et al.
Journal of Affective Disorders (2014) Vol. 174, pp. 296-302
Open Access | Times Cited: 117
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications
Giulia Rivasi, Martina Rafanelli, Enrico Mossello, et al.
Drugs & Aging (2020) Vol. 37, Iss. 10, pp. 725-738
Open Access | Times Cited: 103
Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
Nicolette Stogios, Alexander Gdanski, Philip Gerretsen, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 63
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 49
Quinoline- and Isoquinoline-Sulfonamide Analogs of Aripiprazole: Novel Antipsychotic Agents?
Paweł Zajdel, Anna Partyka, Krzysztof Marciniec, et al.
Future Medicinal Chemistry (2013) Vol. 6, Iss. 1, pp. 57-75
Closed Access | Times Cited: 81
Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse
Brian R. Berridge, Vasanthi Mowat, Hirofumi Nagai, et al.
Journal of Toxicologic Pathology (2016) Vol. 29, Iss. 3_Suppl, pp. 1S-47S
Open Access | Times Cited: 80
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Henry A. Nasrallah, Willie Earley, Andrew J. Cutler, et al.
BMC Psychiatry (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 73
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 67
Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually Eligible Medicaid-Medicare Beneficiaries of Five States
Charles E. Leonard
Journal of Clinical & Experimental Cardiology (2012) Vol. 01, Iss. S10
Open Access | Times Cited: 69
Clozapine-Induced Cardiotoxicity: Role of Oxidative Stress, Tumour Necrosis Factor Alpha and NF-κβ
Basel A. Abdel‐Wahab, Metwally E. Metwally
Cardiovascular Toxicology (2014) Vol. 15, Iss. 4, pp. 355-365
Closed Access | Times Cited: 60
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Suresh Durgam, William M. Greenberg, Dayong Li, et al.
Psychopharmacology (2016) Vol. 234, Iss. 2, pp. 199-209
Open Access | Times Cited: 56
Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram
Ingrid Berling, Geoffrey K. Isbister
Annals of Emergency Medicine (2015) Vol. 66, Iss. 2, pp. 154-164
Closed Access | Times Cited: 55
Protective effect of captopril against clozapine-induced myocarditis in rats: Role of oxidative stress, proinflammatory cytokines and DNA damage
Basel A. Abdel‐Wahab, Metwally E. Metwally, Mohamed M. El-khawanki, et al.
Chemico-Biological Interactions (2014) Vol. 216, pp. 43-52
Closed Access | Times Cited: 53
Cardiovascular safety of antipsychotics: a clinical overview
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, et al.
Expert Opinion on Drug Safety (2016) Vol. 15, Iss. 5, pp. 679-688
Closed Access | Times Cited: 47
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
Ágota Barabássy, B. Sebe, K. Acsai, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 957-970
Open Access | Times Cited: 38
Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats
Heidi N. Boyda, Alfredo Ramos‐Miguel, Ric M. Procyshyn, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 77-90
Open Access | Times Cited: 48
Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability
David Linton, Alasdair M. Barr, William G. Honer, et al.
Current Psychiatry Reports (2013) Vol. 15, Iss. 5
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top